Voluntary Consumption of Sodium Glutamate Solution as a Factor of Depression-Like Behavior in Adult Rats: an Experimental Study
- Authors: Parot'kin D.O.1, Bogdanova N.G.1, Nazarova G.A.1, Sudakov S.K.1
-
Affiliations:
- P. K. Anokhin Research Institute of Normal Physiology
- Issue: Vol 31, No 2 (2023)
- Pages: 169-176
- Section: Original study
- Submitted: 19.07.2022
- Accepted: 19.10.2022
- Published: 16.07.2023
- URL: https://journals.eco-vector.com/pavlovj/article/view/109411
- DOI: https://doi.org/10.17816/PAVLOVJ109411
- ID: 109411
Cite item
Abstract
INTRODUCTION: Use of sodium glutamate solution with food is a widely spread practice. The glutamate-ergic system has been shown to directly participate in the mechanisms of depression, however, up to the moment, no data have been found to evidence that use of sodium glutamate causes depression.
AIM: To study the effect of intake of sodium glutamate on the formation of depression-like behavior in male rats.
MATERIALS AND METHODS: Formation of depression-like behavior was evaluated in male rats of Wistar line with 230 g–250 g weight at the beginning of the experiment in the situation of ‘inescapable swimming’ according to the method of R. D. Porsolt, and of ‘hanging by the tail’ according to T. A. Voronina. In the course of the experiment, the rats of the experimental group consumed 1.1% sodium glutamate solution daily for 30 days, the control animals drank water. During the experiment, the rats were kept in individual cages and had free access to water. The animals of the control group (n = 7) had only water in the drinking bowls. The animals of the experimental group (n = 7) were given water in one drinking bowl and 60 mМ (1.1%) sodium glutamate solution (Henan Lotus Flower Gourmet Powder Cо., LTD, China) in the other.
RESULTS: Consumption of 1.1% sodium glutamate solution for 30 days led to reduction of the time of active movements and to increase in the number of periods of immobilization in animals in both tests. Besides, in the tests for depression-like behavior of animals, increased rhythmologic index of depression was found in the group of rats receiving sodium glutamate solution.
CONCLUSION: Based on the results of study, it was found that chronic voluntary consumption of 60 mM (1.1%) sodium glutamate solution for 30 days provokes the formation of depression-like behavior in rats.
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Daniil O. Parot'kin
P. K. Anokhin Research Institute of Normal Physiology
Author for correspondence.
Email: dobrydaniil@yandex.ru
ORCID iD: 0000-0001-6418-7685
SPIN-code: 7637-0484
Russian Federation, Moscow
Natal'ya G. Bogdanova
P. K. Anokhin Research Institute of Normal Physiology
Email: natbog07@yandex.ru
ORCID iD: 0000-0003-2345-8578
SPIN-code: 5580-9324
Cand. Sci. (Biol.)
Russian Federation, MoscowGalina A. Nazarova
P. K. Anokhin Research Institute of Normal Physiology
Email: g-a-nazarova@rambler.ru
ORCID iD: 0000-0002-7470-1120
SPIN-code: 2506-4688
Cand. Sci. (Biol.)
Russian Federation, MoscowSergey K. Sudakov
P. K. Anokhin Research Institute of Normal Physiology
Email: s-sudakov@nphys.ru
ORCID iD: 0000-0002-9485-3439
SPIN-code: 1127-4090
MD, Dr. Sci. (Med.), Professor
Russian Federation, MoscowReferences
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. doi: 10.1016/S0140-6736(18)32279-7
- World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates [Internet]. Available at: https://www.who.int/publications/i/item/depression-global-health-estimates. Accessed: 2022 October 19.
- World Health Organization. Depressive disorder (depression) [Internet]. Available at: https://www.who.int/news-room/fact-sheets/detail/depression. Accessed: 2022 October 19.
- Jaso BA, Niciu MJ, Iadarola ND, et al. Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder. Curr Neuropharmacol. 2017;15(1):57–70. doi: 10.2174/1570159x14666160321123221
- Hashimoto K, Sawa A, Iyo M. Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry. 2007;62(11):1310–6. doi: 10.1016/j.biopsych.2007.03.017
- Küçükibrahimoğlu E, Saygin MZ, Calişkan M, et al. The change in plasma GABA, glutamine, and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur J Clin Pharmacol. 2009;65(6):571–7. doi: 10.1007/s00228-009-0650-7
- Mazzoli R, Pessione E. The Neuro-endocrinological Role of Microbial Glutamate and GABA Signaling. Front Microbiol. 2016;7:1934. doi: 10.3389/fmicb.2016.01934
- Liang S, Wu X, Hu X, et al. Recognizing Depression from the Microbio-ta-Gut-Brain Axis. Int J Mol Sci. 2018;19(6):1592. doi: 10.3390/ijms19061592
- Kurihara K. Umami the Fifth Basic Taste: History of Studies on Receptor Mechanisms and Role as a Food Flavor. BioMed Res Int. 2015;2015:189402. doi: 10.1155/2015/189402
- Sudakov SK, Bogdanova NG, Alekseeva EV, et al. Endogenous opioid dependence after intermittent use of glucose, sodium chloride, and monosodium glutamate solutions. Food Sci Nutr. 2019;7(9):2842–6. doi: 10.1002/fsn3.1120
- Sudakov SK, Bogdanova NG, Alekseeva EV, et al. The Development of Pathological Dependence after Intermittent Use of Sodium Glutamate, but Not Sucrose or Sodium Chloride Solutions. Bull Exp Biol Med. 2020;169(3):324–7. doi: 10.1007/s10517-020-04879-6
- Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature. 1977;266(5604):730–2. doi: 10.1038/266730a0
- Shchetinin EV, Baturin VA, Arushanian EB. A biorhythmologic approach to evaluating forced swimming as an experimental model of a ‘depressive’ state. Zhurnal Vysshei Nervnoi Deiatelnosti imeni I P Pavlova. 1989;39(5):958–64. (In Russ).
- Garibova TL, Kraineva VA, Voronina TA. Animal models of depression. Farmakokinetika i Farmakodinamika. 2017;(2):14–9. (In Russ).
- Biney RP, Djankpa FT, Osei SA, et al. Effects of in utero exposure to monosodium glutamate on locomotion, anxiety, depression, memory and KCC2 expression in offspring. Int J Dev Neurosci. 2022;82(1):50–62. doi: 10.1002/jdn.10158
- Zhu W, Yang F, Cai X, et al. Role of glucocorticoid receptor phosphorylation-mediated synaptic plasticity in anxiogenic and depressive behaviors induced by monosodium glutamate. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(1):151–64. doi: 10.1007/s00210-020-01845-x
- Li J, Sha L, Xu Q. An early increase in glutamate is critical for the development of depression-like behavior in a chronic restraint stress (CRS) model. Brain Res Bull. 2020;162:59–66. doi: 10.1016/j.brain resbull.2020.05.013
- Adejoke YO, Olakunle JO. Glutamate and depression: Reflecting a deepening knowledge of the gut and brain effects of a ubiquitous molecule. World J Psychiatry. 2021;11(7):297–315. doi: 10.5498/wjp. v11.i7.297
- Torii K, Uneyama H, Nakamura E. Physiological roles of dietary glutamate signaling via gut–brain axis due to efficient digestion and absorption. J Gastroenterol. 2013;48(4):442–51. doi: 10.1007/s00535-013-0778-1
- Onaolapo OJ, Onaolapo AY, Olowe AO. The neurobehavioral implications of the brain and microbiota interaction. Front Biosci (Landmark Ed). 2020;25(2):363–97. doi: 10.2741/4810
- Schousboe A, Scafidi S, Bak LK, et al. Glutamate metabolism in the brain focusing on astrocytes. Adv Neurobiol. 2014;11:13–30. doi: 10.1007/978-3-319-08894-5_2
Supplementary files
![](/img/style/loading.gif)